Interferon-α plus amantadine in chronic hepatitis C resistant to interferon alone: a pilot randomized study

The optimal therapy for patients with chronic hepatitis C who have not responded to interferon (IFN) is still an unsolved issue. The aim of this study was to evaluate the efficacy and tolerability of a high dose of IFN‐α2a plus amantadine for chronic hepatitis C patients who were non‐responders to a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of viral hepatitis 2001-07, Vol.8 (4), p.284-286
Hauptverfasser:	Gaeta, G. B., Stornaiuolo, G., Stanzione, M., Ascione, T., Pasquazzi, C., Taliani, G., Cimino, L., Budillon, G., Piccinino, F.
Format:	Artikel
Sprache:	eng
Schlagworte:	amantadine Amantadine - therapeutic use Antiviral Agents - therapeutic use chronic hepatitis C Drug Resistance, Microbial Drug Therapy, Combination Female Follow-Up Studies Hepatitis C virus Hepatitis C, Chronic - blood Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - metabolism Humans IFN-resistant Interferon-alpha - blood Interferon-alpha - therapeutic use interferon-α Male Pilot Projects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!